SCHEMBL21337802

SCHEMBL21337802

NCc1ccc(F)cc1-n1nnc2ccccc21

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KCNMA1 Q12791 1/20 0.47
▸ ESR1 P03372 1/20 0.43
▸ GRM2 Q14416 2/20 0.41
▸ RAB9A P51151 2/20 0.40
▸ KMT2A Q03164 3/20 0.39
▸ ALDH1A1 P00352 2/20 0.39
▸ CYP1A2 P05177 1/20 0.39
▸ CYP3A4 P08684 1/20 0.39
▸ CYP2D6 P10635 1/20 0.39
▸ MAPT P10636 1/20 0.39
▸ CYP2C9 P11712 1/20 0.39
▸ THPO P40225 1/20 0.39
▸ CYP4Z1 Q86W10 1/20 0.39
▸ MGAM O43451 1/20 0.39
▸ AMY1A P0DUB6 1/20 0.39
▸ GAA P10253 1/20 0.39
▸ SI P14410 1/20 0.39
▸ MGAM2 Q2M2H8 1/20 0.39
▸ SMN1; SMN2 Q16637 3/20 0.39
▸ TSHR P16473 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15109556 0.81 KCNMA1 (0.50) KCNMA1ESR1GRM2RAB9AKMT2A
SCHEMBL12215841 0.77 NPC1 (0.41) RAB9ACYP1A2LMNANPC1
Hydrochloric Acid SCHEMBL2524182 0.76 NPC1 (0.40) RAB9ACYP1A2LMNANPC1
SCHEMBL12175671 0.73 KMT2A (0.59) KCNMA1ESR1RAB9AKMT2AALDH1A1
SCHEMBL19704930 0.72 KCNMA1 (0.47) KCNMA1ESR1GRM2RAB9AKMT2A
SCHEMBL13093779 0.71 KCNMA1 (0.55) KCNMA1GRM2RAB9AKMT2AALDH1A1
SCHEMBL12167112 0.70 KCNMA1 (0.42) KCNMA1ESR1RAB9AKMT2AMGAM
SCHEMBL17188809 0.70 KCNMA1 (0.48) KCNMA1RAB9AKMT2AALDH1A1CYP1A2
SCHEMBL29193554 0.70 RAB9A (0.43) KCNMA1ESR1GRM2RAB9AKMT2A
SCHEMBL28244365 0.69 KCNMA1 (0.61) KCNMA1GRM2RAB9AKMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3536324-A1 4-OXO-3,4-DIHYDRO-1,2,3-BENZOTRIAZINES AS MODULATORS OF GPR139 Takeda Pharmaceutical Company Limited (JP) 2019-09-11 — — EP disclosed
Send feedback